Hyperprogressive disease in patients with unresectable hepatocellular carcinoma receiving atezolizumab plus bevacizumab therapy (vol 52, pg 298, 2022)

被引：0
|
作者：
Maesaka, K.
Sakamori, R.
Yamada, R.
Tahata, Y.
Imai, Y.
Ohkawa, K.
机构：
来源：
HEPATOLOGY RESEARCH | 2022年 / 52卷 / 07期
关键词：
D O I：
10.1111/hepr.13775
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：659 / 659
页数：1
相关论文
共 50 条
  • [21] Atezolizumab plus bevacizumab versus sorafenib or atezolizumab alone for unresectable hepatocellular carcinoma: A systematic review
    Ahmed, Faiza
    Onwumeh-Okwundu, Jennifer
    Yukselen, Zeynep
    Endaya Coronel, Maria-Kassandra
    Zaidi, Madiha
    Guntipalli, Prathima
    Garimella, Vamsi
    Gudapati, Sravya
    Mezidor, Marc Darlene
    Andrews, Kim
    Mouchli, Mohamad
    Shahini, Endrit
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2021, 13 (11) : 1813 - 1832
  • [22] Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma
    Vithayathil, Mathew
    D'Alessio, Antonio
    Weinmann, Arndt
    Galle, Peter
    Fulgenzi, Claudia Angela Maria
    Fessas, Petros
    Bettinger, Dominik
    Bengsch, Bertram
    Vogel, Arndt
    Balcar, Lorenz
    Scheiner, Bernhard
    Muzaffar, Mahvish
    Amara, Suneetha
    Muhammed, Ambreen
    Naqash, Abdul Rafeh
    Personeni, Nicola
    Pressiani, Tiziana
    Cammarota, Antonella
    Pinter, Matthias
    Cortellini, Alessio
    Rimassa, Lorenza
    Pinato, David J.
    Sharma, Rohini
    JOURNAL OF HEPATOLOGY, 2022, 77 : S374 - S375
  • [23] Impact of renal function on the prognosis of patients receiving Atezolizumab/Bevacizumab combination therapy and Lenvatinib monotherapy for unresectable hepatocellular carcinoma
    Takada, Hitomi
    Yamashita, Koji
    Osawa, Leona
    Komiyama, Yasuyuki
    Nakakuki, Natsuko
    Muraoka, Masaru
    Suzuki, Yuichiro
    Sato, Mitsuaki
    Takano, Shinichi
    Fukasawa, Mitsuharu
    Yamaguchi, Tatsuya
    Maekawa, Shinya
    Takahashi, Kazuya
    Uchimura, Kohei
    Enomoto, Nobuyuki
    ONCOLOGY, 2023, 101 (10) : 609 - 623
  • [24] Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma
    Vithayathil, Mathew
    D'Alessio, Antonio
    Fulgenzi, Claudia Angela Maria
    Nishida, Naoshi
    Schoenlein, Martin
    von Felden, Johann
    Schulze, Kornelius
    Wege, Henning
    Saeed, Anwaar
    Wietharn, Brooke
    Hildebrand, Hannah
    Wu, Linda
    Ang, Celina
    Marron, Thomas U.
    Weinmann, Arndt
    Galle, Peter R.
    Bettinger, Dominik
    Bengsch, Bertram
    Vogel, Arndt
    Balcar, Lorenz
    Scheiner, Bernhard
    Lee, Pei-Chang
    Huang, Yi-Hsiang
    Amara, Suneetha
    Muzaffar, Mahvish
    Naqash, Abdul Rafeh
    Cammarota, Antonella
    Zanuso, Valentina
    Pressiani, Tiziana
    Pinter, Matthias
    Cortellini, Alessio
    Kudo, Masatoshi
    Rimassa, Lorenza
    Pinato, David J.
    Sharma, Rohini
    HEPATOLOGY INTERNATIONAL, 2023, 17 (04) : 904 - 914
  • [25] Variceal bleeding following treatment with atezolizumab plus bevacizumab in two patients with unresectable hepatocellular carcinoma
    Matsui, Teppei
    Nagai, Hidenari
    Mukozu, Takanori
    Wakui, Noritaka
    Matsuda, Takahisa
    Igarashi, Yoshinori
    CLINICAL JOURNAL OF GASTROENTEROLOGY, 2024, 17 (06) : 1058 - 1066
  • [26] Atezolizumab plus bevacizumab versus sorafenib or atezolizumab alone for unresectable hepatocellular carcinoma: A systematic review
    Faiza Ahmed
    Jennifer Onwumeh-Okwundu
    Zeynep Yukselen
    Maria-Kassandra Endaya Coronel
    Madiha Zaidi
    Prathima Guntipalli
    Vamsi Garimella
    Sravya Gudapati
    Marc Darlene Mezidor
    Kim Andrews
    Mohamad Mouchli
    Endrit Shahini
    World Journal of Gastrointestinal Oncology, 2021, 13 (11) : 1813 - 1832
  • [27] OPTIMAL SUBSEQUENT THERAPY FOR UNRESECTABLE HEPATOCELLULAR CARCINOMA PATIENTS PROGRESSED ON ATEZOLIZUMAB PLUS BEVACIZUMAB THERAPY, APPROPRIATE TO THE RADIOLOGICAL PROGRESSION PATTERNS
    Tokunaga, Takayuki
    Sugi, Kazuhiro
    Kudo, Koichi
    Sakai, Yoshinari
    Miyase, Shiho
    Fukubayashi, Kotaro
    Tateyama, Masakuni
    Tanaka, Kentaro
    Narahara, Satoshi
    Inada, Hiroki
    Iio, Etsuko
    Yoshimaru, Yoko
    Watanabe, Takehisa
    Nagaoka, Katsuya
    Setoyama, Hiroko
    Tanaka, Yasuhito
    HEPATOLOGY, 2024, 80
  • [28] Tumor steatosis and glutamine synthetase expression in patients with advanced hepatocellular carcinoma receiving atezolizumab plus bevacizumab therapy
    Kurebayashi, Yutaka
    Tsujikawa, Hanako
    Sugimoto, Katsutoshi
    Yunaiyama, Daisuke
    Araki, Yoichi
    Saito, Kazuhiro
    Takahashi, Hiroshi
    Kakegawa, Tatsuya
    Wada, Takuya
    Tomita, Yusuke
    Abe, Masakazu
    Yoshimasu, Yu
    Takeuchi, Hirohito
    Hirata, Taiki
    Sakamaki, Kentaro
    Kakimi, Kazuhiro
    Nagao, Toshitaka
    Itoi, Takao
    Sakamoto, Michiie
    HEPATOLOGY RESEARCH, 2023, 53 (10) : 1008 - 1020
  • [29] Atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma: Early clinical experience
    Hiraoka, Atsushi
    Kumada, Takashi
    Tada, Toshifumi
    Hirooka, Masashi
    Kariyama, Kazuya
    Tani, Joji
    Atsukawa, Masanori
    Takaguchi, Koichi
    Itobayashi, Ei
    Fukunishi, Shinya
    Tsuji, Kunihiko
    Ishikawa, Toru
    Tajiri, Kazuto
    Ochi, Hironori
    Yasuda, Satoshi
    Toyoda, Hidenori
    Ogawa, Chikara
    Nishimura, Takashi
    Hatanaka, Takeshi
    Ohama, Hideko
    Nouso, Kazuhiro
    Morishita, Asahiro
    Tsutsui, Akemi
    Nagano, Takuya
    Itokawa, Norio
    Okubo, Tomomi
    Arai, Taeang
    Imai, Michitaka
    Koizumi, Yohei
    Nakamura, Shinichiro
    Joko, Kouji
    Iijima, Hiroko
    Hiasa, Yoichi
    Kudo, Masatoshi
    CANCER REPORTS, 2022, 5 (02)
  • [30] Hyperprogressive disease during atezolizumab plus bevacizumab treatment in patients with advanced hepatocellular carcinoma from Japanese real-world practice
    Sae Yumita
    Sadahisa Ogasawara
    Miyuki Nakagawa
    Susumu Maruta
    Tomomi Okubo
    Norio Itokawa
    Yotaro Iino
    Masamichi Obu
    Yuki Haga
    Atsuyoshi Seki
    Tadayoshi Kogure
    Takamasa Ishino
    Keita Ogawa
    Kisako Fujiwara
    Terunao Iwanaga
    Naoto Fujita
    Takafumi Sakuma
    Ryuta Kojima
    Hiroaki Kanzaki
    Keisuke Koroki
    Masanori Inoue
    Kazufumi Kobayashi
    Soichiro Kiyono
    Masato Nakamura
    Naoya Kanogawa
    Tomoko Saito
    Takayuki Kondo
    Ryo Nakagawa
    Shingo Nakamoto
    Ryosuke Muroyama
    Tetsuhiro Chiba
    Ei Itobayashi
    Masanori Atsukawa
    Yoshihiro Koma
    Ryosaku Azemoto
    Kenji Ito
    Hideaki Mizumoto
    Jun Kato
    Naoya Kato
    BMC Gastroenterology, 23
12345